More on CPRX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-100.0% Growth)
- Ratings (9.2 Score)
- Holders
- FDA Archive

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (8/6/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Catalyst Pharmaceuticals (NQ:CPRX)
Delayed: 24.24 -0.08 (0.33%)
Prev. Close $24.32  
Open$24.00 
52 Wk High$3.00 
52 Wk Low$0.51 
Day High$24.25 
Day Low$23.63 
P/E N/A  
EPS$-0.25 
Volume654,699 

Friends, Peers and Foes (?): XLO, ACAD, ALKS, AXSM, HRMY (more...)

Mar 6, 2026 08:04 AM Catalyst Pharmaceuticals presents DMD research at MDA conference
Mar 6, 2026 08:03 AM Catalyst Pharmaceuticals to Showcase Real‑World Findings in Duchenne Muscular Dystrophy and Host Vamorolone-Focused Symposium at the 2026 MDA Clinical & Scientific Conference
Mar 6, 2026 08:03 AM Catalyst Pharmaceuticals to Showcase Real‑World Findings in Duchenne Muscular Dystrophy and Host Vamorolone-Focused Symposium at the 2026 MDA Clinical & Scientific Conference
Mar 3, 2026 05:44 AM Catalyst Pharmaceutical Partners (CPRX) PT Raised to $35 at Citi
Feb 27, 2026 06:00 AM Oppenheimer Reiterates Outperform Rating on Catalyst Pharmaceutical Partners (CPRX)
Feb 25, 2026 04:35 PM Catalyst Pharmaceuticals (CPRX) Tops Q4 EPS by 37c, Offers Guidance
Feb 25, 2026 04:24 PM Form 8-K CATALYST PHARMACEUTICALS For: Feb 25
Feb 25, 2026 04:07 PM Form 10-K CATALYST PHARMACEUTICALS For: Dec 31
Feb 25, 2026 04:07 PM Catalyst Pharmaceuticals Reports Record Fourth Quarter and Record Full Year 2025 Financial Results and Provides 2026 Financial Guidance
Feb 24, 2026 08:03 AM Catalyst Pharmaceuticals to Participate in the Barclays 28th Annual Global Healthcare Conference
View All Articles

Entities mentioned with CPRX

View All Entities